[Corrigendum] DR2 blocker thioridazine: A promising drug for ovarian cancer therapy

• Authors:
  • Min Yong
  • Tinghe Yu
  • Si Tian
  • Shuaibin Liu
  • Jiao Xu
  • Jianguo Hu
  • Lina Hu

• View Affiliations

  
  Affiliations: Department of Obstetrics and Gynecology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China, Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, P.R. China, Department of Rehabilitation, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, P.R. China
• Published online on: September 9, 2020     https://doi.org/10.3892/ol.2020.12081
• Article Number: 218

• Copyright : © Yong et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

View Figures

Figure 1